CBRE GROUP INC - A (CBRE) Fundamental Analysis & Valuation

NYSE:CBRE • US12504L1098

Current stock price

151.51 USD
+3.71 (+2.51%)
At close:
151.544 USD
+0.03 (+0.02%)
After Hours:

This CBRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CBRE Profitability Analysis

1.1 Basic Checks

  • In the past year CBRE was profitable.
  • In the past year CBRE had a positive cash flow from operations.
  • CBRE had positive earnings in each of the past 5 years.
  • In the past 5 years CBRE always reported a positive cash flow from operatings.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CBRE has a Return On Assets of 3.75%. This is amongst the best in the industry. CBRE outperforms 87.10% of its industry peers.
  • With an excellent Return On Equity value of 13.03%, CBRE belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 5.08%, CBRE is doing good in the industry, outperforming 75.81% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CBRE is in line with the industry average of 5.47%.
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROIC 5.08%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CBRE has a better Profit Margin (2.85%) than 66.13% of its industry peers.
  • In the last couple of years the Profit Margin of CBRE has declined.
  • The Operating Margin of CBRE (3.19%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CBRE has declined.
  • The Gross Margin of CBRE (18.66%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CBRE has remained more or less at the same level.
Industry RankSector Rank
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CBRE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBRE is destroying value.
  • Compared to 1 year ago, CBRE has less shares outstanding
  • Compared to 5 years ago, CBRE has less shares outstanding
  • The debt/assets ratio for CBRE is higher compared to a year ago.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 3.13 indicates that CBRE is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CBRE (3.13) is better than 70.97% of its industry peers.
  • CBRE has a debt to FCF ratio of 6.56. This is a slightly negative value and a sign of low solvency as CBRE would need 6.56 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 6.56, CBRE is doing good in the industry, outperforming 69.35% of the companies in the same industry.
  • CBRE has a Debt/Equity ratio of 0.87. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
  • CBRE has a Debt to Equity ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Altman-Z 3.13
ROIC/WACC0.59
WACC8.56%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that CBRE should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, CBRE is doing worse than 70.97% of the companies in the same industry.
  • CBRE has a Quick Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CBRE has a Quick ratio of 1.09. This is in the lower half of the industry: CBRE underperforms 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CBRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.05% over the past year.
  • The Earnings Per Share has been growing by 14.27% on average over the past years. This is quite good.
  • CBRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.38%.
  • CBRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.22% yearly.
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.85% on average over the next years. This is quite good.
  • CBRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.11% yearly.
EPS Next Y19.08%
EPS Next 2Y17.68%
EPS Next 3Y16.12%
EPS Next 5Y16.85%
Revenue Next Year11.57%
Revenue Next 2Y10.31%
Revenue Next 3Y9.86%
Revenue Next 5Y9.11%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. CBRE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.71 indicates a rather expensive valuation of CBRE.
  • 72.58% of the companies in the same industry are more expensive than CBRE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.87. CBRE is around the same levels.
  • Based on the Price/Forward Earnings ratio of 19.91, the valuation of CBRE can be described as rather expensive.
  • 80.65% of the companies in the same industry are more expensive than CBRE, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 38.51. CBRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.71
Fwd PE 19.91
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 70.97% of the companies listed in the same industry.
  • CBRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 69.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.23
EV/EBITDA 21.08
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CBRE may justify a higher PE ratio.
  • CBRE's earnings are expected to grow with 16.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.24
PEG (5Y)1.66
EPS Next 2Y17.68%
EPS Next 3Y16.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBRE Dividend Analysis

5.1 Amount

  • CBRE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE Fundamentals: All Metrics, Ratios and Statistics

CBRE GROUP INC - A

NYSE:CBRE (4/17/2026, 8:04:00 PM)

After market: 151.544 +0.03 (+0.02%)

151.51

+3.71 (+2.51%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-12
Earnings (Next)04-23
Inst Owners99.1%
Inst Owner Change0.03%
Ins Owners0.6%
Ins Owner Change4.48%
Market Cap44.41B
Revenue(TTM)40.55B
Net Income(TTM)1.16B
Analysts83
Price Target184.01 (21.45%)
Short Float %1.25%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.04%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.74%
Min EPS beat(4)0.04%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)7.3%
EPS beat(16)15
Avg EPS beat(16)8.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)1.13%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)-3.11%
PT rev (3m)-3.2%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)3.51%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)3.48%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE 23.71
Fwd PE 19.91
P/S 1.1
P/FCF 37.23
P/OCF 28.49
P/B 5
P/tB N/A
EV/EBITDA 21.08
EPS(TTM)6.39
EY4.22%
EPS(NY)7.61
Fwd EY5.02%
FCF(TTM)4.07
FCFY2.69%
OCF(TTM)5.32
OCFY3.51%
SpS138.33
BVpS30.29
TBVpS-3.91
PEG (NY)1.24
PEG (5Y)1.66
Graham Number65.9875 (-56.45%)
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROCE 6.97%
ROIC 5.08%
ROICexc 5.57%
ROICexgc 11.69%
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
FCFM 2.94%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
ROICexc(3y)6.87%
ROICexc(5y)8.07%
ROICexgc(3y)14.53%
ROICexgc(5y)18.56%
ROCE(3y)8.23%
ROCE(5y)9.39%
ROICexgc growth 3Y-21.33%
ROICexgc growth 5Y-6.1%
ROICexc growth 3Y-16.05%
ROICexc growth 5Y-7%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Debt/EBITDA 3.46
Cap/Depr 39.44%
Cap/Sales 0.9%
Interest Coverage 2.89
Cash Conversion 70.19%
Profit Quality 103.11%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 3.13
F-Score5
WACC8.56%
ROIC/WACC0.59
Cap/Depr(3y)44.67%
Cap/Depr(5y)43.27%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.86%
Profit Quality(3y)88.53%
Profit Quality(5y)96.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
EPS Next Y19.08%
EPS Next 2Y17.68%
EPS Next 3Y16.12%
EPS Next 5Y16.85%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%
Revenue Next Year11.57%
Revenue Next 2Y10.31%
Revenue Next 3Y9.86%
Revenue Next 5Y9.11%
EBIT growth 1Y-15.16%
EBIT growth 3Y-0.84%
EBIT growth 5Y5.11%
EBIT Next Year50.39%
EBIT Next 3Y22.85%
EBIT Next 5Y16.26%
FCF growth 1Y-14.85%
FCF growth 3Y-4.48%
FCF growth 5Y-5.27%
OCF growth 1Y-8.72%
OCF growth 3Y-1.46%
OCF growth 5Y-3.16%

CBRE GROUP INC - A / CBRE Fundamental Analysis FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status for CBRE stock?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


How profitable is CBRE GROUP INC - A (CBRE) stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


What is the financial health of CBRE GROUP INC - A (CBRE) stock?

The financial health rating of CBRE GROUP INC - A (CBRE) is 5 / 10.


What is the earnings growth outlook for CBRE GROUP INC - A?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 19.08% in the next year.